Commentary

Editorial: The Meaning of AIDS—Then and Now


 

References

The ironies of AIDS are incredible. Until a few years ago, we were struggling along “just” trying to come up with a cure (cures) for cancer, when suddenly the struggle became a science-fiction nightmare no one would have believed possible: an infectious disease that causes cancer, spread both sexually and intravenously. And yet while the problem itself has grown, the scientific advances toward a solution have also been progressing in an incredibly short period of time—identification of an etiologic organism followed by a blood test indicating exposure in just a few years.

If we could consider the scientific advances alone, we could all stand around and justifiably congratulate ourselves. But of course, the advances are overshadowed by the disease itself. Will a vaccine be available in 3 to 5 years? A cure in 5 to 10? Will we ultimately cure cancer in curing AIDS? Or will we see a new “Darwinian selection” of the biologically fittest?

To get to the year 2000, we will have to continue to set aside nuclear weapons, effectively balance the world population with the world food supply, and cure or control AIDS and any similar new disease that may develop. To get to 1987, those of us who deal with medical emergencies daily will have to treat the complications of AIDS with the medications and antibiotics available, counsel our patients as best we can, reassure the public to the limits of current scientific knowledge, and neither panic ourselves nor become complacent in handling the needles and biological material that are part of everyday patient care.

It almost makes one long for the “good old days” of the 1970s, when aids were aids and the practice of medicine seemed so much simpler.

—Neal Flomenbaum, MD, New York

Pages

Recommended Reading

Subspecialty outpatient clinics, EDs miss many flu vaccination opportunities
MDedge Emergency Medicine
Renal ultrasound in neonates with febrile UTI can rule out high-grade vesicoureteral reflux
MDedge Emergency Medicine
Attention to risk factors could reduce CAP-related emergency revisits
MDedge Emergency Medicine
FDA approves oritavancin for skin infections
MDedge Emergency Medicine
Settling a malpractice suit is seldom a straightforward decision
MDedge Emergency Medicine
Chikungunya vaccine safe, immunogenic in phase I trial
MDedge Emergency Medicine
Too much reliance on oximetry in bronchiolitis
MDedge Emergency Medicine
Novel antiviral therapy 100% protective against lethal Ebola-like Marburg virus
MDedge Emergency Medicine
Crises inform updated critical care recommendations for disasters
MDedge Emergency Medicine
NIH set to begin human testing on experimental Ebola vaccine
MDedge Emergency Medicine